Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

Blood

Volumn 97, Issue 10, 2001, Pages 2962-2971

  Rocha, Vanderson ^a   Cornish, Jacqueline ^b   Sievers, Eric L ^c   Filipovich, Alexandra ^d   Locatelli, Franco ^e   Peters, Cristina ^f   Remberger, Mats ^g   Michel, Gérard ^h   Arcese, William ⁱ   Dallorso, Sandro ^j   Tiedemann, Karin ^k   Busca, Alessandro ^l   Chan, Ka Wah ^m   Kato, Shunichi ⁿ   Ortega, Juan ^o   Vowels, Marcus ^p   Zander, Axel ^q   Souillet, Gérard ^r   Oakill, Anthony ^b   Woolfrey, Ann ^c   Pay, Andrea L ^s   Green, Ann ^t   Gamier, Federico ^a   Ionescu, Irina ^a   Wernet, Peter ^u   Sirchia, Girolamo ^v   Rubinstein, Pablo ^w   Chevret, Sylvie ^a   Gluckman, Eliane ^a   more..

^a SAINT LOUIS HOSPITAL   (France)

^b Hospital for Sick Children   (United Kingdom)

^c Fred Hutchinson Cancer Research Center   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h TIMONE HOSPITAL   (France)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j G GASLINI INSTITUTE   (Italy)

^k ROYAL CHILDREN'S HOSPITAL   (Australia)

^l REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁿ TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^p SYDNEY CHILDREN'S HOSPITAL   (Australia)

^q UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^r HÔPITAL DEBROUSSE   (France)

^s Anthony Nolan Bone Marrow Research Institute   (United Kingdom)

^t NHS BLOOD AND TRANSPLANT   (United Kingdom)

^u Duesseldorf Cord Blood Bank   (Germany)

^v Milano Cord Blood Bank   (Italy)

^w New York Cord Blood Bank   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; LYMPHOCYTE DEPLETION; MALE; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0035874490     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.2962     Document Type: Article

References (36)

1. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med. 1998;339:1177-1193.
2. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
3. Ash RC, Casper JT, Chitambar CR, et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med. 1990;322:485-494.
4. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA identical siblings. J Clin Oncol. 1997;15:1767-1777.
5. Henslee-Downey PJ, Gluckman E. Allogeneic transplantation from donors other than HLA-identical siblings. Hematology/Oncology Clinics of North America. 1999;13:1017-1039.
6. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828-3832.
7. Gluckman E, Rocha V, Chevret S. Related and unrelated cord blood transplantation. In: SBA Cohen, E Gluckman, P Rubinstein, JA Madrigal, eds. Cord blood characteristics: Role in stem cell transplantation. London, UK: Martin Dunitz Ltd; 2000:205-216.
8. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186-1193.
9. Rubinstein P, Rosenfield RD, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81:1679-1690.
10. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119-10122.
11. Lazzari L, Corsini C, Curioni C, et al. The Milan cord blood bank and the Italian cord blood network. J of Hematotherapy. 1996;5:117-121.
12. Wernet P, Koegler G, Hakenberg P, et al. Standards and efficiency of cord blood banking by the international Netcord organization. Blood. 1999;94:344b.
13. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease. Lancet. 1995;346:214-219.
14. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
15. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graftversus-host disease. Blood. 1996;88:795-802.
16. Gluckman E, Rocha V, Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med. 1997;337:373-381.
17. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
18. Rocha V, Wagner JE, Sobocinski K, et al. Comparison of graft-versus-host disease in children transplanted with HLA identical sibling umbilical cord blood versus HLA identical sibling bone marrow transplant. N Engl J of Med. 2000;342:1846-1854.
19. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662-3671.
20. Woolfrey AE, Frangoul H, Anasetti C, et al. Unrelated bone marrow transplants for children with acute lymphoblastic leukemia. Blood. 1999;94:712a.
21. Hongeng S, Krance RA, Bowman LC, et al. Outcomes of transplantation with matched-sibling and unrelated donor bone marrow in children with leukemia. Lancet. 1997;350:767-771.
22. Green A, Clarke E, Hunt L, et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood. 1999;94:2236-2246.
23. Balduzzi A, Gooley T, Anasetti C, et al. Unrelated donor marrow transplantation in children. Blood. 1995;86:3247-3256.
24. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood. 1997;89:3864-3872.
25. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
26. Storb R, Prentice RL, Sullivan KM, et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplantation from HLA-identical siblings. Ann Intern Med. 1983;98:461-466.
27. Horowitz MM, Gale RP, Sondel PM, et al. Graftversus-leukemia after bone marrow transplantation. Blood. 1990;75:555-562.
28. Kook H, Goldman F, Padley D, et al. Reconstruction of the immune system after unrelated or partially mismatched T-cell depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood. 1996;88:1089-1097.
29. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of age and donor leukocyte infusions. Blood. 1999;93:467-480.
30. Scott I, O'Shea M, Tiercy JM, et al. Molecular typing shows a high level of HLA class I incompatibility in serologically well-matched donor patients pairs: implications for unrelated bone marrow donor selection. Blood. 1998;92:1-9.
31. Speiser D, Tiercy J, Rufer N, et al. Relation between the resolution of HLA typing and the chance of finding an unrelated bone marrow donor. Bone Marrow Transplant. 1994;13:805-809.
32. Madrigal AJ, Scott I, Arguello R, et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev. 1997;157:153-166.
33. Frassoni F, Labopin M, Powles R, et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Lancet. 2000;355:1393-1398.
34. Sierra J, Storer B, Hansen AJ, Bierke JW, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997;89:4226-4235.
35. Martin PJ, Akatsuka Y, Hahne M, Sale G. Involvement of donor T-cell toxic effector mechanisms in preventing allogeneic marrow rejection. Blood. 1998;92:2177-2181.
36. Koegler G, Nurnberger J, Fisher J, et al, Simultaneous cord blood transplantation of ex-vivo expanded together with nonexpanded cells for high risk leukemia. Bone Marrow Transplant. 1999;24:397-403.